Shares of N4 Pharma Plc (LON:N4P – Get Free Report) were up 15.5% on Wednesday . The company traded as high as GBX 0.70 ($0.01) and last traded at GBX 0.66 ($0.01). Approximately 336,244 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 1,181,155 shares. The stock had previously closed at GBX 0.58 ($0.01).
N4 Pharma Price Performance
The company has a market cap of £2.37 million, a P/E ratio of -55.00 and a beta of -0.37. The firm’s 50-day moving average is GBX 0.64 and its two-hundred day moving average is GBX 0.58. The company has a debt-to-equity ratio of 1.62, a current ratio of 22.73 and a quick ratio of 7.28.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than N4 Pharma
- Industrial Products Stocks Investing
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Best Aerospace Stocks Investing
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
